Brydon L Bennett from 10835 Ashlar Pl, San Diego, CA 92131, age 57, Phone: (858)5308057

Methods For Treating Inflammatory Conditions Or Inhibiting Jnk
view source
US Patent:

7335676, Feb 26, 2008
Filed:

Dec 16, 2003
Appl. No.:

10/738640
Inventors:

Brydon L. Bennett - San Diego CA, US
Shripad S. Bhagwat - San Diego CA, US
Anthony M. Manning - San Diego CA, US
Brion W. Murray - San Diego CA, US
Eoin C. O'Leary - San Diego CA, US
Yoshitaka Satoh - San Diego CA, US
Assignee:

Signal Pharmaceuticals, LLC - San Diego CA
International Classification:

A61K 31/415
US Classification:

514406
Abstract:

This invention generally relates to methods for treating or preventing an inflammatory disease or disorder comprising administering to a patient in need thereof an effective amount of a Pyrazoloanthrone Derivative having the following structure:.

Methods Of Treatment And Prevention Using Haloaryl Substituted Aminopurines
view source
US Patent:

7759342, Jul 20, 2010
Filed:

Feb 15, 2007
Appl. No.:

11/708150
Inventors:

Brydon L. Bennett - San Diego CA, US
Kate Blease - San Diego CA, US
Brian Edwin Cathers - San Diego CA, US
Assignee:

Signal Pharmaceuticals, LLC - San Diego CA
International Classification:

A61P 11/00
C07D 473/32
C07D 239/50
C07D 239/48
A61K 31/53
A61P 3/10
US Classification:

5142342, 5142634
Abstract:

Provided herein are Aminopurine Compounds having the following structure:.

Methods Of Modulating Inflammatory Cell Recruitment And Gene Expression Using Haloaryl Substituted Aminopurines
view source
US Patent:

8440661, May 14, 2013
Filed:

May 13, 2010
Appl. No.:

12/779083
Inventors:

Brydon L. Bennett - San Diego CA, US
Kate Northcote - San Diego CA, US
Brian Edwin Cathers - San Diego CA, US
Assignee:

Signal Pharmaceuticals, LLC - San Diego CA
International Classification:

A61P 11/00
C07D 473/32
C07D 239/50
C07D 239/48
A61K 31/53
A61P 3/10
US Classification:

5142342, 5142634
Abstract:

Provided herein are Aminopurine Compounds having the following structure:.

Methods For Treating Inflammatory Conditions Or Inhibiting Jnk
view source
US Patent:

20040072888, Apr 15, 2004
Filed:

Mar 24, 2003
Appl. No.:

10/395810
Inventors:

Brydon Bennett - San Diego CA, US
Shripad Bhagwat - San Diego CA, US
Anthony Manning - San Diego CA, US
Brion Murray - San Diego CA, US
Eoin O'Leary - San Diego CA, US
Yoshitaka Satoh - San Diego CA, US
International Classification:

C07D231/54
A61K031/416
US Classification:

514/406000, 548/358500
Abstract:

This invention generally relates to methods for treating or preventing an inflammatory disease or disorder comprising administering to a patient in need thereof an effective amount of a Pyrazoloanthrone Derivative having the following structure: or a pharmaceutically acceptable salt thereof, wherein Rand Rare as defined herein.

Methods For Preserving Tissue
view source
US Patent:

20050266391, Dec 1, 2005
Filed:

Jan 14, 2005
Appl. No.:

11/035842
Inventors:

Brydon Bennett - San Diego CA, US
David Brenner - New York NY, US
Jerome Zeldis - Princeton NJ, US
International Classification:

A01N001/00
US Classification:

435001100, 514406000
Abstract:

The invention generally relates to methods for preserving tissue, preventing reperfusion injury to implanted tissue, preventing transplant rejection or preserving a cell to be transplanted, comprising contacting tissue or a cell with an effective amount of a JNK Inhibitor. The invention further relates to compositions useful for the preservation of tissue, the compositions comprising an effective amount of a JNK Inhibitor.

Methods For Treating, Preventing And Managing Chronic Lymphocytic Leukemia With Indazole Compounds
view source
US Patent:

20070060616, Mar 15, 2007
Filed:

Aug 30, 2006
Appl. No.:

11/512836
Inventors:

Brydon Bennett - San Diego CA, US
Shripad Bhagwat - San Diego CA, US
International Classification:

A61K 31/454
US Classification:

514322000
Abstract:

This invention is generally directed to the use of Indazole Compounds for treating or preventing chronic lymphocytic leukemia. The methods comprise the treatment or prevention of chronic lymphocytic leukemia comprising administering an effective amount of an indazole compound, or a pharmaceutically acceptable salt or composition thereof, to a patient in need thereof.

Methods Of Treatment, Improvement And Prevention Using Haloaryl Substituted Aminopurines
view source
US Patent:

20120129807, May 24, 2012
Filed:

Oct 20, 2011
Appl. No.:

13/277282
Inventors:

Brydon L. Bennett - San Diego CA, US
Brian Edwin Cathers - San Diego CA, US
Heather Raymon - San Diego CA, US
Weilin Xie - San Diego CA, US
Jaman May Maroni - Watchung NJ, US
International Classification:

A61K 31/69
A61K 31/5377
A61P 17/00
A61K 31/551
A61P 17/06
A61P 17/04
A61P 1/04
A61P 1/00
A61P 1/10
A61P 19/02
A61P 17/14
A61P 11/00
A61P 17/02
A61P 1/12
A61K 31/52
US Classification:

514 64, 5142634, 51426322, 51426323, 51426324, 5142632, 5142342, 51425216, 514218, 51425211
Abstract:

Provided herein are Aminopurine Compounds having the following structure:wherein R, Rand Rare as defined herein, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing scleroderma, keloids, UV injury, or sunburn, and methods for improving or preventing scar formation.

Substituted Diaminocarboxamide And Diaminocarbonitrile Pyrimidines, Compositions Thereof, And Methods Of Treatment Therewith
view source
US Patent:

20130029987, Jan 31, 2013
Filed:

Apr 20, 2012
Appl. No.:

13/451574
Inventors:

Brydon L. Bennett - San Diego CA, US
Jan Elsner - San Diego CA, US
Paul Erdman - San Diego CA, US
Robert Hilgraf - San Diego CA, US
Laurie Ann LeBrun - San Diego CA, US
Meg McCarrick - San Diego CA, US
Mehran F. Moghaddam - Carlsbad CA, US
Mark A. Nagy - San Diego CA, US
Stephen Norris - San Diego CA, US
David A. Paisner - Portland OR, US
Marianne Sloss - San Diego CA, US
William J. Romanow - San Diego CA, US
Yoshitaka Satoh - Poway CA, US
Jayashree Tikhe - San Diego CA, US
Won Hyung Yoon - San Diego CA, US
Mercedes Delgado - San Diego CA, US
International Classification:

A61K 31/505
C07D 405/12
C07D 401/12
A61K 31/506
C07D 405/14
C12N 5/071
C07D 413/12
A61K 31/5377
A61P 1/16
A61P 3/10
A61P 3/00
C07D 239/48
C07D 403/12
US Classification:

5142358, 544323, 514275, 544324, 544296, 544122, 544230, 435375
Abstract:

Provided herein are Diaminopyrimidine Compounds having the following structures:

Brydon L Bennett